What Is Minimal Residual Disease (MRD)?

Published on

Minimal residual disease (MRD) is the term used for the small number of cancer cells that remain in the body during or after treatment. Monitoring MRD can help to provide insights into a patient’s disease and treatment path. View this video to learn more about MRD,  advances in next-generation testing, the impact of test results, and tools for communicating with your healthcare team.

Sponsored by Adaptive Biotechnologies.

Please remember the opinions expressed on Patient Power are not necessarily the views of our sponsors, contributors, partners or Patient Power. Our discussions are not a substitute for seeking medical advice or care from your own doctor. That’s how you’ll get care that’s most appropriate for you.

Featuring

Give Feedback

Related Programs

What Is the Role of Minimal Residual Disease (MRD) Testing in Myeloma Care?

What is the role of MRD testing in myeloma care? Tune in to hear renowned myeloma expert Dr. Rafael Fonseca explain what MRD testing can detect about a patient’s response to therapy, remaining myeloma cells and what it means for the course of treatment.

Published:

Advertisement
Join Our Community Register for Events Read Our Latest Blog
Advertisement

Page last updated on November 14, 2018